Genentech Executive Vice President Richard Scheller discusses some of the thought-provoking ethical issues that arise in the drug development process. To illuminate the issue, Scheller describes the painful challenges of the clinical trial placebo process, often required by the Food and Drug Administration. He also articulates some of the ethical implications related to drug costs and insurance reimbursements.
Related
Toni Townes-Whitley,
Microsoft
The Ethics of Innovation [Entire Talk]
Tech innovators must index on larger social issues like fairness, accessibility and the effect on jobs to stay relevant.
Toni Townes-Whitley,
Microsoft
The Ethics of Innovation [Entire Talk]
Tech innovators must index on larger social issues like fairness, accessibility and the effect on jobs to stay relevant.
David Eagleman,
Stanford School of Medicine
A Brainy Approach to Innovation [Entire Talk]
Renowned neuroscientist David Eagleman shares his passion for translating the complexities of cognition into mind-blowing inventions and educational material for the masses. The public-television host, bestselling author and Stanford adjunct professor speaks with Tina Seelig of the Stanford Technology Ventures Program about his decision to leave the lab and dedicate his life to bringing scientific discoveries into the world.
David Eagleman,
Stanford School of Medicine
A Brainy Approach to Innovation [Entire Talk]
Renowned neuroscientist David Eagleman shares his passion for translating the complexities of cognition into mind-blowing inventions and educational material for the masses. The public-television host, bestselling author and Stanford adjunct professor speaks with Tina Seelig of the Stanford Technology Ventures Program about his decision to leave the lab and dedicate his life to bringing scientific discoveries into the world.
Carlos Watson,
Ozy Media
Taking a Lead From Tech [Entire Talk]
Carlos Watson, co-founder and CEO of Ozy Media, describes how its forward-focused digital news magazine, Ozy, looks more toward innovators in business sectors outside traditional media. The Emmy-winning journalist shares the unlikely origins of his entrepreneurial drive, and explains how his wide-ranging career has been fueled by family, curiosity and the thrill of starting fresh.
Carlos Watson,
Ozy Media
Taking a Lead From Tech [Entire Talk]
Carlos Watson, co-founder and CEO of Ozy Media, describes how its forward-focused digital news magazine, Ozy, looks more toward innovators in business sectors outside traditional media. The Emmy-winning journalist shares the unlikely origins of his entrepreneurial drive, and explains how his wide-ranging career has been fueled by family, curiosity and the thrill of starting fresh.
